[Does isoniazid change the prognosis of primary infection in its pulmonary lymph node form?].
D010131:Aminosalicylic Acid / Q000627:therapeutic use*; D002648:Child; D003141:Communicable Diseases; D006801:Humans; D007223:Infant; D007538:Isoniazid; D008198:Lymph Nodes; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use*; D011379:Prognosis; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary
D009539:Nicotinic Acids; D009525:Niacin; D010131:Aminosalicylic Acid; D007538:Isoniazid; D013307:Streptomycin
NICOTINIC ACID ISOMERS/therapeutic use; PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/in infant and child
L'isoniazide a-t-il transformé le pronostic de la primo-infection dans sa forme ganglio-pulmonaire?